New facility will revolutionise research into neurological conditions
11 November 2021
Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø President & Provost Dr Michael Spence, Professor Alan Thompson and colleagues explain how the new centre of excellence for Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Neuroscience will help revolutionise the development of treatments for neurological diseases.
The state-of-the-art facilities will be home to three bodies: the world-leading Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Queen Square Institute of Neurology; the headquarters of the UK Dementia Research Institute, which is the single biggest investment the UK has ever made in dementia; and the Ïã¸ÛÁùºÏ²ÊÖÐÌØÍøH National Hospital for Neurology and Neurosurgery (NHNN), which is the UK's largest dedicated neurological and neurosurgical hospital.
It will bring together research scientists, clinicians and patients to create a world-class research and treatment environment for conditions including dementia, Alzheimer’s disease, multiple sclerosis, Huntington’s disease, neuromuscular diseases, Parkinson’s disease, motor neuron diseases, stroke and epilepsy.
Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø signed a contract with construction partner ISG to deliver the 17,500m2 state-of-the-art new neuroscience facility, and demolition and construction are now underway with the building due to be completed in 2024.
Earlier this year Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø’s President & Provost was joined by ISG and University College London Hospitals NHS Foundation Trust to break ground at the site on Grays Inn Road.